Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Swissmedic Key 67467001 Registration Holder Medius AG Name Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 02.04.2020 Introduction of Sequence 02.04.2020 ATC-Classification (Codice) Revision date WHO Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 456.84 Limitation Yes Limitation text
Deductible 10 % Consumer price 513.25 Feedback FB GTIN 7680674670018 Medication Code Biotechnologika Pharmacode Disponibility
Composition trastuzumabum 150 mg, histidinum, histidini hydrochloridum monohydricum, macrogolum 3350, sorbitolum 115.2 mg, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium 0.07 mg. Packungsbestandteile Galenic Form Excipiens Active Agent Dose Trastuzumab 150 mg
BAG: Active Agent Dose Trastuzumab 150 mg
Inactive agents Dose Histidin Hydrochloride Monohydrate Histidine Macrogol 3350 Sodium Hydroxide Sorbitol 115.2 mg
Source Data was imported : 07.08.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
